Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Qiagen NV’s stock clocked out at $46.43, up 0.83% from its previous closing price of $46.05. In other words, the price has increased by $0.83 from its previous closing price. On the day, 0.53 million shares were traded. QGEN stock price reached its highest trading level at $46.58 during the session, while it also had its lowest trading level at $46.01.
Ratios:
To gain a deeper understanding of QGEN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.46 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.27.
On December 19, 2023, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $44.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 10318788608 and an Enterprise Value of 10803096576. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 147.96, and their Forward P/E ratio for the next fiscal year is 20.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 23.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.31 while its Price-to-Book (P/B) ratio in mrq is 3.03. Its current Enterprise Value per Revenue stands at 5.568 whereas that against EBITDA is 29.618.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.38, which has changed by 0.068941474 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $46.55, while it has fallen to a 52-week low of $34.74. The 50-Day Moving Average of the stock is 7.92%, while the 200-Day Moving Average is calculated to be 8.88%.
Shares Statistics:
It appears that QGEN traded 1.08M shares on average per day over the past three months and 1087970 shares per day over the past ten days. A total of 226.45M shares are outstanding, with a floating share count of 221.37M. Insiders hold about 0.21% of the company’s shares, while institutions hold 61.92% stake in the company. Shares short for QGEN as of 1722384000 were 2739629 with a Short Ratio of 2.54, compared to 1719532800 on 3098896. Therefore, it implies a Short% of Shares Outstanding of 2739629 and a Short% of Float of 1.6099999999999999.
Dividends & Splits
The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2024-01-30 with an ex-dividend date of 1706572800. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
Earnings Estimates
The current rating of Qiagen NV (QGEN) reflects the combined expertise of 11.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.6, with high estimates of $0.65 and low estimates of $0.59.
Analysts are recommending an EPS of between $2.23 and $2.03 for the fiscal current year, implying an average EPS of $2.14. EPS for the following year is $2.28, with 20.0 analysts recommending between $2.45 and $2.2.
Revenue Estimates
In the current quarter, 10 analysts expect revenue to total $492.11M. It ranges from a high estimate of $498M to a low estimate of $489.48M. As of the current estimate, Qiagen NV’s year-ago sales were $475.89MFor the next quarter, 10 analysts are estimating revenue of $526.83M. There is a high estimate of $551M for the next quarter, whereas the lowest estimate is $520.49M.
A total of 20 analysts have provided revenue estimates for QGEN’s current fiscal year. The highest revenue estimate was $2.01B, while the lowest revenue estimate was $1.97B, resulting in an average revenue estimate of $1.98B. In the same quarter a year ago, actual revenue was $1.97BBased on 20 analysts’ estimates, the company’s revenue will be $2.1B in the next fiscal year. The high estimate is $2.15B and the low estimate is $2.05B.
